Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free CRNX Stock Alerts $49.42 -1.47 (-2.89%) (As of 05:21 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Crinetics Pharmaceuticals Stock Price Performance5 Day Performance+4.70%1 Month Performance+5.35%3 Month Performance+25.24%6 Month Performance+85.16%Year-To-Date Performance+38.90%1 Year Performance+109.41% Receive CRNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. CRNX Stock Chart for Thursday, May, 9, 2024 CRNX Chart by TradingView Crinetics Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$47.66$50.89+6.78%$51.29$48.471.93 million shs$4.01 billion05/07/2024$46.50$47.66+2.49%$48.14$46.60677,922 shs$3.75 billion05/06/2024$47.20$46.50-1.48%$48.11$46.20561,205 shs$3.66 billion05/03/2024$46.78$47.20+0.90%$48.37$47.13679,390 shs$3.72 billion05/02/2024$45.05$46.78+3.84%$46.96$44.84608,945 shs$3.68 billion05/01/2024$43.82$45.05+2.81%$45.99$43.661.10 million shs$3.55 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$44.00$43.82-0.41%$44.54$43.16575,153 shs$3.45 billion04/29/2024$42.12$44.00+4.46%$45.15$41.59676,132 shs$3.06 billion04/26/2024$42.29$42.12-0.40%$42.87$41.67563,205 shs$2.93 billion04/25/2024$43.32$42.29-2.38%$42.83$41.05591,321 shs$2.94 billion04/24/2024$44.22$43.32-2.04%$45.26$43.28421,077 shs$3.02 billion04/23/2024$43.44$44.22+1.80%$44.78$42.05612,425 shs$3.08 billion04/22/2024$42.97$43.44+1.09%$43.76$42.71465,271 shs$3.02 billion04/19/2024$43.01$42.97-0.09%$44.21$42.20624,655 shs$2.99 billion04/18/2024$44.01$43.01-2.27%$44.54$42.87538,897 shs$2.99 billion04/17/2024$43.49$44.01+1.20%$44.31$43.28507,335 shs$3.06 billion04/16/2024$43.68$43.49-0.43%$44.29$42.63472,414 shs$3.03 billion04/15/2024$44.59$43.68-2.04%$44.88$43.44540,666 shs$3.04 billion04/12/2024$48.03$44.59-7.16%$48.23$43.711.11 million shs$3.10 billion04/11/2024$45.90$48.03+4.64%$48.53$46.20684,737 shs$3.34 billion04/10/2024$46.91$45.90-2.15%$46.50$45.17534,956 shs$3.19 billion04/09/2024$46.44$46.91+1.01%$47.23$46.09668,499 shs$3.26 billion04/08/2024$47.53$46.44-2.29%$48.31$45.75550,241 shs$3.23 billion04/05/2024$46.65$47.53+1.89%$48.63$45.52668,211 shs$3.31 billion04/04/2024$47.62$46.65-2.04%$49.58$46.001.23 million shs$3.25 billion04/03/2024$46.00$47.62+3.52%$48.13$44.912.91 million shs$3.31 billion04/02/2024$46.53$46.00-1.14%$46.07$44.43858,683 shs$3.20 billion04/01/2024$46.81$46.53-0.60%$47.62$44.521.09 million shs$3.24 billion03/29/2024$46.81$46.81$47.16$44.011.29 million shs$3.26 billion03/28/2024$44.43$46.81+5.36%$47.16$44.011.29 million shs$3.26 billion03/27/2024$43.37$44.43+2.44%$44.64$43.10836,861 shs$3.09 billion03/26/2024$43.12$43.37+0.58%$44.28$42.68618,794 shs$3.02 billion03/25/2024$44.29$43.12-2.64%$44.52$42.33651,584 shs$3.00 billion03/22/2024$44.97$44.29-1.51%$45.00$43.72599,537 shs$3.08 billion03/21/2024$45.49$44.97-1.14%$46.00$44.65860,836 shs$3.13 billion03/20/2024$45.18$45.49+0.69%$46.76$42.701.67 million shs$3.17 billion03/19/2024$37.93$45.18+19.11%$45.98$40.983.09 million shs$3.14 billion03/18/2024$38.93$37.93-2.57%$39.06$37.52773,547 shs$2.64 billion03/15/2024$38.21$38.93+1.88%$39.38$37.961.73 million shs$2.71 billion03/14/2024$40.50$38.21-5.65%$40.36$37.45791,400 shs$2.66 billionProof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story.03/13/2024$40.75$40.50-0.61%$41.92$39.96643,152 shs$2.82 billion03/12/2024$41.57$40.75-1.97%$41.76$40.45525,974 shs$2.84 billion03/11/2024$42.29$41.57-1.70%$42.50$41.40514,471 shs$2.89 billion03/08/2024$42.50$42.29-0.49%$44.33$41.59396,183 shs$2.94 billion03/07/2024$43.52$42.50-2.34%$43.59$42.32524,918 shs$2.96 billion03/06/2024$42.93$43.52+1.37%$45.14$43.05429,690 shs$3.03 billion03/05/2024$43.51$42.93-1.33%$44.07$42.40663,589 shs$2.99 billion03/04/2024$46.03$43.51-5.47%$47.58$42.93667,961 shs$3.03 billion03/01/2024$40.94$46.03+12.43%$47.01$41.221.12 million shs$3.07 billion02/29/2024$42.76$40.94-4.26%$45.94$40.581.35 million shs$2.73 billion02/28/2024$40.47$42.76+5.66%$47.34$42.381.86 million shs$2.86 billion02/27/2024$38.67$40.47+4.65%$40.79$38.50731,800 shs$2.70 billion02/26/2024$36.85$38.67+4.94%$38.70$36.75418,462 shs$2.58 billion02/23/2024$36.72$36.85+0.35%$37.60$36.48349,054 shs$2.46 billion02/22/2024$36.40$36.72+0.88%$37.43$36.10473,746 shs$2.45 billion02/21/2024$37.42$36.40-2.73%$37.72$36.11385,249 shs$2.43 billion02/20/2024$37.82$37.42-1.06%$38.31$36.81457,807 shs$2.50 billion02/19/2024$37.82$37.82$37.90$36.58489,100 shs$2.53 billion02/16/2024$36.92$37.82+2.44%$37.90$36.73488,952 shs$2.53 billion02/15/2024$36.31$36.92+1.68%$37.25$35.86575,874 shs$2.47 billion02/14/2024$35.99$36.31+0.89%$36.76$35.79560,835 shs$2.43 billion02/13/2024$39.30$35.99-8.42%$38.14$35.821.31 million shs$2.40 billion02/12/2024$39.46$39.30-0.41%$40.50$39.12650,678 shs$2.63 billion02/09/2024$38.46$39.46+2.61%$39.49$38.33514,741 shs$2.64 billion02/08/2024$37.78$38.46+1.79%$39.19$37.38821,330 shs$2.57 billion Related Companies: Summit Therapeutics Stock Chart Biohaven Stock Chart Axsome Therapeutics Stock Chart Insmed Stock Chart Ultragenyx Pharmaceutical Stock Chart Prestige Consumer Healthcare Stock Chart Alkermes Stock Chart Perrigo Stock Chart HUTCHMED Stock Chart Xenon Pharmaceuticals Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.